IO Biotech Inc (IOBT)
0.8538
-0.12
(-11.98%)
USD |
NASDAQ |
Nov 14, 16:00
0.88
+0.03
(+3.07%)
After-Hours: 20:00
IO Biotech Shareholders Equity (Quarterly): 96.27M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 96.27M |
| March 31, 2024 | 115.47M |
| December 31, 2023 | 133.16M |
| September 30, 2023 | 157.59M |
| June 30, 2023 | 104.52M |
| March 31, 2023 | 124.22M |
| December 31, 2022 | 138.85M |
| Date | Value |
|---|---|
| September 30, 2022 | 153.49M |
| June 30, 2022 | 172.18M |
| March 31, 2022 | 193.69M |
| December 31, 2021 | 211.92M |
| September 30, 2021 | -19.65M |
| June 30, 2021 | -18.33M |
| December 31, 2020 | -35.30M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-35.30M
Minimum
Dec 2020
211.92M
Maximum
Dec 2021
109.15M
Average
128.69M
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co Inc | 44.50B |
| NovaBay Pharmaceuticals Inc | -0.617M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |
| Theriva Biologics Inc | 27.65M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 111.47M |
| Total Liabilities (Quarterly) | 15.20M |